New pancreatic cancer pill could reshape treatment as early trial results stun researchers
Sentiment Mix
Expert Signals
Fox News - Latest Headlines
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
Supported by 1 story
Related Events
The little-known Medicare surtax may hammer millions in Obamacare tax battle
Uncategorized • 5/18/2026
Knicks-Cavs conference finals will be determined by a new brand of Cleveland Kryptonite — Jimmy Watkins - Cleveland.com
Research • 5/18/2026
San Antonio Spurs vs Oklahoma City Thunder Prediction, Pick, Odds for NBA Western Conference Finals Game 1 - Action Network
Research • 5/18/2026
Leaked images reveal Sony’s 10th anniversary ‘ColleXion’ headphones - The Verge
Uncategorized • 5/18/2026
Trump drops $10bn lawsuit against IRS in exchange for a settlement fund
Uncategorized • 5/18/2026